Chou C H, Aarons L, Rowland M
School of Pharmacy and Pharmaceutical Sciences, University of Manchester, United Kingdom.
J Pharmacokinet Biopharm. 1998 Oct;26(5):595-615. doi: 10.1023/a:1023229318017.
The axial dispersion model of hepatic drug elimination is characterized by two dimensionless parameters, the dispersion number, DN, and the efficiency number, RN, corresponding to the relative dispersion of material on transit through the organ and the relative efficiency of elimination of drug by the organ, respectively. Optimal design theory was applied to the estimation of these two parameters based on changes in availability (F) of drug at steady state for the closed boundary condition model, with particular attention to variations in the fraction of drug unbound in the perfusate (fuB). Sensitivity analysis indicates that precision in parameter estimation is greatest when F is low and that correlation between RN and DN is high, which is desirable for parameter estimation, when DN lies between 0.1 and 100. Optimal design points were obtained using D-optimization, taking into account the error variance model. If the error variance model is unknown, it is shown that choosing Poisson error model is reasonable. Furthermore, although not optimal, geometric spacing of fuB values is often reasonable and definitively superior to a uniform spacing strategy. In practice, the range of fuB available for selection may be limited by such practical considerations as assay sensitivity and acceptable concentration range of binding protein. Notwithstanding, optimal design theory provides a rational approach to precise parameter estimation.
肝脏药物消除的轴向弥散模型由两个无量纲参数表征,即弥散数(DN)和效率数(RN),分别对应物质在器官中转运时的相对弥散以及器官对药物的相对消除效率。基于封闭边界条件模型稳态下药物可用性(F)的变化,将最优设计理论应用于这两个参数的估计,特别关注灌注液中游离药物分数(fuB)的变化。敏感性分析表明,当F较低时,参数估计的精度最高;当DN在0.1至100之间时,RN与DN之间的相关性较高,这对于参数估计是有利的。考虑误差方差模型,使用D优化获得最优设计点。如果误差方差模型未知,结果表明选择泊松误差模型是合理的。此外,尽管不是最优的,但fuB值的几何间距通常是合理的,并且肯定优于均匀间距策略。在实践中,可供选择的fuB范围可能受到诸如分析灵敏度和结合蛋白可接受浓度范围等实际因素的限制。尽管如此,最优设计理论为精确的参数估计提供了一种合理的方法。